IRIS
DI PASQUA, LAURA GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.207
AS - Asia 1.452
EU - Europa 1.298
SA - Sud America 223
AF - Africa 32
OC - Oceania 4
Totale 5.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.153
CN - Cina 676
IE - Irlanda 413
SG - Singapore 314
RU - Federazione Russa 244
HK - Hong Kong 220
BR - Brasile 178
DE - Germania 158
FI - Finlandia 112
IT - Italia 111
VN - Vietnam 103
GB - Regno Unito 47
CA - Canada 36
SE - Svezia 33
FR - Francia 32
JP - Giappone 32
BE - Belgio 29
UA - Ucraina 28
IN - India 27
CZ - Repubblica Ceca 26
AR - Argentina 20
PL - Polonia 17
BD - Bangladesh 16
MX - Messico 16
ZA - Sudafrica 12
EC - Ecuador 11
ID - Indonesia 10
TR - Turchia 8
AT - Austria 7
ES - Italia 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
LT - Lituania 6
CO - Colombia 5
IQ - Iraq 5
KR - Corea 5
NL - Olanda 5
IL - Israele 4
MA - Marocco 4
PK - Pakistan 4
DZ - Algeria 3
JO - Giordania 3
LV - Lettonia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
GR - Grecia 2
IM - Isola di Man 2
IR - Iran 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
MY - Malesia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
TH - Thailandia 1
TM - Turkmenistan 1
VE - Venezuela 1
Totale 5.216
Salva come PNG Salva come JPEG
Città #
Chandler 455
Dublin 411
Beijing 229
Hong Kong 220
Ashburn 175
Dallas 163
Singapore 132
Boardman 86
Los Angeles 84
Helsinki 74
Moscow 68
Munich 68
Shanghai 68
Princeton 65
Lawrence 63
Medford 61
Nanjing 51
New York 50
Jacksonville 49
Wilmington 44
Pavia 41
Ann Arbor 38
Ho Chi Minh City 36
Redondo Beach 32
Tokyo 32
Brussels 29
Buffalo 29
Hebei 25
Hanoi 23
Changsha 22
Turku 22
Brno 21
Milan 21
Nanchang 20
Hangzhou 18
São Paulo 17
Warsaw 17
Atlanta 16
The Dalles 15
Tianjin 15
Toronto 15
Brooklyn 14
Santa Clara 13
Seattle 13
Shenyang 13
Houston 12
Montreal 12
Jiaxing 11
Columbus 10
Düsseldorf 10
Johannesburg 10
Monza 10
San Francisco 10
Chennai 9
Mexico City 9
Poplar 9
Chicago 8
Denver 8
Frankfurt am Main 8
London 8
Orem 8
Berlin 7
Des Moines 7
Fairfield 7
Falkenstein 7
Falls Church 7
Lauterbourg 7
Nuremberg 7
Cagliari 6
Guangzhou 6
Ankara 5
Belo Horizonte 5
Charlotte 5
Da Nang 5
Dhaka 5
Raleigh 5
Redwood City 5
Rio de Janeiro 5
Stockholm 5
Washington 5
Amsterdam 4
Brdo 4
Dearborn 4
Guayaquil 4
Haiphong 4
Laurel 4
Paris 4
Quito 4
Seoul 4
Vienna 4
Xi'an 4
Abu Dhabi 3
Alexandria 3
Americana 3
Amman 3
Baghdad 3
Bismarck 3
Biên Hòa 3
Boston 3
Brescia 3
Totale 3.507
Salva come PNG Salva come JPEG
Nome #
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. 153
Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress 142
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress 122
Metabolic shift in liver: correlation between perfusion temperature and hypoxia inducible factor-1α. 113
Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease 107
Changes in biliary levels of arginine and its methylated derivatives after hepatic ischaemia/reperfusion 105
Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models 105
Liver plays a central role in asymmetric dimethylarginine-mediated organ injury 102
Fluorescing fatty acids in rat fatty liver models 98
Serum and hepatic autofluorescence as a real-time diagnostic tool for early cholestasis assessment 95
Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation 95
Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma 92
Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae 92
Increase in transporter MATE-1 expression induced by obeticholic acid correlates with higher biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 90
Lobe-specific heterogeneity in asymmetric dimethylarginine and matrix metalloproteinase levels in a rat model of obstructive cholestasis. 89
Alterations in stearoyl-CoA-desaturase index and metalloproteinase activity in nutritional versus genetic rat models of NAFLD 88
Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury 86
Liver graft susceptibility during static cold storage and dynamic machine perfusion: DCD versus fatty livers 84
Immobilized amyloid Aβ peptides support platelet adhesion and activation 83
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update 83
Fatty acid desaturase involvement in non-alcoholic fatty liver disease rat models: Oxidative stress versus metalloproteinases 80
Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: Current issues and future perspectives in preclinical and clinical research 80
Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet 80
Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium 78
Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract 77
Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury 77
Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV. 77
Liver injury and changes in biliary, tissue and serum levels of Asymmetric Dimethylarginine: role of Obeticholic Acid, a Farnesoid X Receptor agonist. 74
Fatty liver susceptibility to preservation injury using static cold storage versus dynamic machine perfusion 74
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters 72
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury 70
MicroCT evaluation of low-density segmented volume in II, IV and VII-week MCD rats 70
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 69
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 68
Obeticholic acid restores hepatic RECK content in a diet-induced ob/ob mouse model of NASH 68
Fluorescence excitation properties of bilirubin in solution and in serum 68
Spectrofluorometric analysis of autofluorescing components of crude serum from a rat liver model of ischemia and reperfusion 67
Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats 66
The FXR agonist obeticholic acid decreases matrix metalloproteinase activity via RECK and TIMP modulation in hepatic ischemia/reperfusion injury 66
Autofluorescence detection of liver oxidative damage products 65
The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis 63
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors 63
SAT-389-Obeticholic acid reduces matrix metalloproteinases activity via iNOS modulation in hepatic ischemia/reperfusion injury 60
Metabotropic glutamate receptor blockade reduces preservation damage in livers from donors after cardiac death 59
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 58
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 58
P0006 : Hepatic ischemia/reperfusion induces changes in tissue and biliary levels of arginine and its methylated derivatives 58
OCA administration reduces lung matrix metalloproteinase activation following hepatic ischemia/reperfusion injury in rats 58
Selective Blockade of Metabotropic Glutamate Receptor by MPEP Protects against Hepatic Cold Ischemia and Reperfusion Injury 58
Hepatic ischemic injury decreases using negative allosteric modulators of metabotropic glutamate receptor subtype 5 58
INOS-mediated decrease of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 57
Negative allosteric modulators of metabotropic glutamate receptor subtype 5 protect against hepatic ischemia/reperfusion injury 57
SerpinB3 administration protects liver against ischemia-reperfusion injury 56
Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion 55
Changes in glutathione content in liver diseases: An update 55
NAD(P)H and Flavin Autofluorescence Correlation with ATP in Rat Livers with Different Metabolic Steady-State Conditions 54
MPEP administration reduces steatosis and inflammation in ob/ob mice 54
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion 53
Machine perfusion at 20°C prevents ischemic injury and reduces hypoxia-inducible factor-1α expression during rat liver preservation 52
Lobe-specific oxidative stress and matrix metalloproteinase activation in two animal models of non-alcoholic fatty liver disease (NAFLD) 52
MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice 51
Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH 51
Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist 51
MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis 49
The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury 48
Oxidative stress, mitochondria damage and matrix metalloprotease activation in the pathogenesis of NAFLD 48
Targeting mitochondrial complex I modulates lipid metabolism, inflammation and hepatic fibrosis in a MCD-diet model of benign steatosis 46
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 43
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 43
Upregulation of MATE-1 transporter by obeticholic acid correlates with increased biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury 43
Mitochondrial Complex I modulator (CIM) reduces lipid accumulation and inflammation in MCD-diet fed rats 42
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats 39
Obeticholic acid reduces lipid accumulation and fibrosis in a diet-induced ob/ob mouse model of NASH 39
Innovative targets involved in the progression of NASH: Asymmetric-dymethylarginine (ADMA) and its cationic transporters 31
Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management 30
Metalloproteinases activation involvement in the progression of liver injury from NAFLD to NASH 29
Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways 24
Rauwolfia vomitoria (Apocynaceae): A comprehensive insight into its botany, ethnomedicinal uses, pharmacology, phytochemistry, and clinical trials 22
Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries 21
Molecular Targets in Liver Disease 4
Totale 5.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 20 18 23 13 12 9 2
2021/2022325 2 3 4 3 7 6 4 26 5 11 101 153
2022/20231.207 138 112 12 136 59 128 1 58 489 12 49 13
2023/2024480 78 54 23 24 39 83 49 30 1 20 31 48
2024/20251.270 26 86 22 21 20 92 102 38 332 76 157 298
2025/20261.537 203 168 327 313 398 128 0 0 0 0 0 0
Totale 5.362